Researchers conducted a study that assessed how the COVID-19 pandemic affected outcomes of HIV care, including outpatient visits, HIV viral load surveillance, virologic suppression, and mental health encounters.
A woman with HIV who received an umbilical cord blood transplant has become the third person in the world to recover from the virus that causes AIDS.
Researchers examined the prevalence of co-occurring psychiatric and medical conditions of pregnant individuals hospitalized with and without cannabis use disorder by concomitant substance use disorders.
About one in four Hispanic persons tested for HIV are aware of preexposure prophylaxis (PrEP) and about one in five of those eligible for referral are referred to PrEP providers.
Researchers attempted to determine if medications for opioid use disorder integrated with infectious disease measures can lead to better infectious disease outcomes.
With the number of studies reporting sexual orientation and gender identity disparities in mental health rising in the past 20 years, sexual and gender minority individuals have been found to be at a greater risk in accessing and maintaining good health than those identifying as heterosexual. Among the highest disparity are those related to alcohol, tobacco, and other drug use.
A body of emerging research is attempting to quantify changes occurring as a result of the impact of COVID-19 on the HIV pandemic.
Study researchers sought to differentiate between HIV-associated neurocognitive disorder and true Alzheimer disease in patients with HIV.
Investigators studied longer-term treatment with an integrated intervention with psychosocial counseling and supported referrals for antiretroviral therapy and substance use treatment.
Structural concerns, racial and socioeconomic issues, and state- and federal-level policy present challenges when trying to address the intersecting epidemics of opioid use disorder and HIV.
